2seventy bio Inc [TSVT] stock is trading at $5.01, up 3.94%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TSVT shares have gain 4.16% over the last week, with a monthly amount glided 9.15%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
2seventy bio Inc [NASDAQ: TSVT] stock has seen the most recent analyst activity on June 06, 2024, when Goldman downgraded its rating to a Sell and also revised its price target to $2 from $5. Previously, Leerink Partners upgraded its rating to Outperform on January 31, 2024, and elevated its price target to $18. On January 31, 2024, downgrade downgraded it’s rating to Market Perform. Leerink Partners downgraded its rating to a Market Perform but stick to its price target of $6 on October 30, 2023. Citigroup initiated its recommendation with a Buy and recommended $13 as its price target on October 12, 2023. Goldman downgraded its rating to Neutral for this stock on September 13, 2023, but kept the price target unchanged to $5. In a note dated September 12, 2023, Guggenheim downgraded an Neutral rating on this stock.
2seventy bio Inc [TSVT] stock has fluctuated between $1.53 and $6.40 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. 2seventy bio Inc [NASDAQ: TSVT] shares were valued at $5.01 at the most recent close of the market. An investor can expect a potential drop of -60.08% based on the average TSVT price forecast.
Analyzing the TSVT fundamentals
2seventy bio Inc [NASDAQ:TSVT] reported sales of 44.12M for the trailing twelve months, which represents a drop of -75.12%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -4.69%, Pretax Profit Margin comes in at -3.54%, and Net Profit Margin reading is -3.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.62 and Total Capital is -0.44. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.87 points at the first support level, and at 4.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.09, and for the 2nd resistance point, it is at 5.17.
Ratios To Look Out For
For context, 2seventy bio Inc’s Current Ratio is 4.76. In addition, the Quick Ratio stands at 4.76 and the Cash Ratio stands at 2.37. Considering the valuation of this stock, the price to sales ratio is 5.85, the price to book ratio is 1.10.
Transactions by insiders
Recent insider trading involved Snow Jessica,, that happened on Aug 14 ’24 when 7816.0 shares were sold. Officer, JESSICA SNOW completed a deal on Aug 14 ’24 to buy 7816.0 shares. Meanwhile, Chief Financial Officer Eatwell Victoria sold 13.0 shares on Aug 05 ’24.
